Elsevier Inc.

SHERPA: Unknown

People

  1. Riely
    Riely
  2. Kris
    Kris
  3. D'Angelo
    D'Angelo
  4. Janjigian
    Janjigian
  5. Ladanyi
    Ladanyi
  6. Park
    Park
  7. Rekhtman
    Rekhtman
  8. Rusch
    Rusch
  9. Shen
    Shen
  10. Sigel
    Sigel

Groups

  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. Center for Pancreatic Cancer Research (2)
  5. GSK Faculty (2)
  6. Human Oncology and Pathogenesis Program (2)
  7. Surgery (2)
  8. Tow Center for Developmental Oncology (TCDO) (2)
  9. Biostatistics Service (1)
  10. Epidemiology and Biostatistics (1)
Search Within
  1. "2011"
  2. "Maureen Zakowski"
Formats
  1. Journal Article (5)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. Center for Pancreatic Cancer Research (2)
  5. GSK Faculty (2)
  6. Human Oncology and Pathogenesis Program (2)

More Groups

People
  1. Maureen Zakowski (5)
  2. Gregory Riely (3)
  3. Andre Moreira (2)
  4. Carlie Sigel (2)
  5. Marc Ladanyi (2)
  6. Mark Kris (2)

More People

Years
  1. 2011 (5)
Publications
  1. Journal of Thoracic Oncology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Subtyping of non-small cell lung carcinoma: A comparison of small biopsy and cytology specimens
    Journal Article

    Sigel, C. S.; Moreira, A. L.; Travis, W. D.; Zakowski, M. F.; Thornton, R. H.; Riely, G. J.; Rekhtman, N.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Policies and reporting guidelines for small biopsy specimens of mediastinal masses
    Journal Article

    Marchevsky, A.; Marx, A.; Stròˆbel, P.; Suster, S.; Venuta, F.; Marino, M.; Yousem, S.; Zakowski, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: High accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing
    Journal Article

    Rekhtman, N.; Brandt, S. M.; Sigel, C. S.; Friedlander, M. A.; Riely, G. J.; Travis, W. D.; Zakowski, M. F.; Moreira, A. L.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations
    Journal Article

    Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Frequency of EGFR and KRAS mutations in lung adenocarcinomas in african americans
    Journal Article

    Reinersman, J. M.; Johnson, M. L.; Riely, G. J.; Chitale, D. A.; Nicastri, A. D.; Soff, G. A.; Schwartz, A. G.; Sima, C. S.; Ayalew, G.; Lau, C.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save